Literature DB >> 2433794

Atherosclerosis of the internal mammary artery. Histopathological analysis and implications on its results in coronary artery bypass graft surgery.

C A Mestres, A Rives, A Igual, C Vehi, M Murtra.   

Abstract

To evaluate internal mammary artery (IMA) atherosclerosis in our population, 38 segments of IMA obtained at the time of coronary surgery and 20 segments of IMA obtained at postmortem studies were histologically studied. Hematoxilin-eosin, Masson trichromic, elastic fibers and reticulin fibers were the stain methods used. A total of 236 sections were studied. Atherosclerosis was graded from 0 to 4 according to Kay and co-workers. Severe disease, with more than 50% luminal narrowing was found in one necropsy case (5%) and in no surgical case. In the surgical group, only one case (2.36%) showed a degree 3 luminal narrowing (between 25% and 50% luminal reduction). The remaining sections were normal or minimally affected. It is concluded that the IMA shows minimal atherosclerotic changes, being considered a protected vessel.

Entities:  

Mesh:

Year:  1986        PMID: 2433794     DOI: 10.1055/s-2007-1022172

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  3 in total

1.  A comparison of early mortality and morbidity after single and bilateral internal mammary artery grafting with the free right internal mammary artery.

Authors:  S S Ashraf; N Shaukat; K Akhtar; H Love; J Shaw; D J Rowlands; D Keenan
Journal:  Br Heart J       Date:  1994-10

2.  A pathohistological and biochemical study of arteriosclerosis in the internal thoracic artery, a vessel commonly used as a graft in coronary artery bypass surgery.

Authors:  H Kobayashi; S Kitamura; K Kawachi; R Morita; Y Konishi; M Tsutsumi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  Transforming growth factor-β in graft vessels: histology and immunohistochemistry.

Authors:  Shi-Min Yuan; Yan-Qing Wang; Yi Shen; Hua Jing
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.